The postdialytic rise in the plasma total homocysteine concentration is delayed
- PMID: 12169841
- DOI: 10.1159/000063100
The postdialytic rise in the plasma total homocysteine concentration is delayed
Abstract
Background/aims: The mechanism behind the uremic hyperhomocysteinemia has not been elucidated. Possibly, dialyzable uremic toxins play a role, e.g. as enzyme inhibitors. If so, the conditions for enzymatic removal would be expected to improve after dialysis. Therefore, we studied the postdialytic pattern of the plasma total homocysteine (tHcy) concentration.
Methods: We collected blood samples from 19 stable, vitamin-supplemented hemodialysis patients before and at 5, 60, as well as at 480 min after a dialysis session. The patients were studied after dialysis with a low-flux dialyzer (Polyflux 6L) and a high-flux dialyzer (Polyflux 14S).
Results: The mean predialytic plasma tHcy concentration was 13.3 micromol/l which is considerably lower than the concentrations observed in our previous studies. In all patients, the plasma tHcy concentration fell during treatment with both types of dialyzers (average decrease 28 +/- 7%, p < 0.0001, and 31 +/- 8%, p < 0.0001, respectively). No postdialytic change in the plasma tHcy concentration was observed at 60 min after low-flux dialysis, however, after high-flux dialysis, the plasma tHcy concentration was significantly lower at 60 min postdialysis than at 5 min (3 +/- 8%, p < 0.05). At 480 min after dialysis, a significant postdialytic increase in the plasma tHcy concentration was found (6 +/- 9%, p < 0.01, and 11 +/- 5%, p < 0.0001, respectively) both in the case of low-flux and high-flux treatment.
Conclusion: In the postdialytic phase, we observed a short-lived stability in the plasma tHcy concentration, and in the case of high-flux dialysis, even a slight decrease in the plasma tHcy concentration. The results support the hypothesis that dialyzable substances interfere with homocysteine removal.
Copyright 2002 S. Karger AG, Basel
Similar articles
-
Washout of water-soluble vitamins and of homocysteine during haemodialysis: effect of high-flux and low-flux dialyser membranes.Nephrology (Carlton). 2008 Oct;13(5):384-9. doi: 10.1111/j.1440-1797.2008.00946.x. Epub 2008 May 30. Nephrology (Carlton). 2008. PMID: 18518942
-
[The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?].Acta Med Croatica. 2006 Jun;60(3):201-8. Acta Med Croatica. 2006. PMID: 16933832 Croatian.
-
Influence of hemodialysis membrane permeability on serum levels of advanced glycation end products (AGEs) and homocysteine metabolites.Clin Nephrol. 2004 Mar;61(3):191-7. doi: 10.5414/cnp61191. Clin Nephrol. 2004. PMID: 15077870 Clinical Trial.
-
Effect of dialyser membrane pore size on plasma homocysteine levels in haemodialysis patients.Nephrol Dial Transplant. 2003 Dec;18(12):2596-600. doi: 10.1093/ndt/gfg437. Nephrol Dial Transplant. 2003. PMID: 14605283
-
Long-term reduction of plasma homocysteine levels by super-flux dialyzers in hemodialysis patients.Kidney Int. 2001 Jan;59(1):342-7. doi: 10.1046/j.1523-1755.2001.00496.x. Kidney Int. 2001. PMID: 11135089
Cited by
-
High-flux versus low-flux membranes for end-stage kidney disease.Cochrane Database Syst Rev. 2012 Sep 12;2012(9):CD005016. doi: 10.1002/14651858.CD005016.pub2. Cochrane Database Syst Rev. 2012. PMID: 22972082 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical